Nautilus Biotechnology, Inc. (NAUT) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NAUT Revenue Growth
NAUT Revenue Analysis (2018–2025)
As of May 8, 2026, Nautilus Biotechnology, Inc. (NAUT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, NAUT's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including CDNA (+19.2% YoY), SEER (+14.5% YoY), and QBTS (+178.5% YoY). Compare NAUT vs CDNA →
NAUT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NAUTCurrent | $0 | - | - | - | |
 CDNA | $380M | +19.2% | +14.6% | -5.5% | |
 SEER | $14M | +14.5% | +160.6% | -717.7% | |
 QBTS | $25M | +178.5% | +36.7% | -408.2% | |
 ILMN | $4.3B | +1.2% | +6.0% | 19.9% | |
 PACB | $160M | +3.9% | +15.2% | -348.5% |
NAUT Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-6,465,000 | - | $-66,837,000 | - |
| 2024 | $0 | - | $-6,353,000 | - | $-81,476,000 | - |
| 2023 | $0 | - | $-5,705,000 | - | $-76,152,000 | - |
| 2022 | $0 | - | $-3,416,000 | - | $-63,618,000 | - |
| 2021 | $0 | - | $-2,842,000 | - | $-50,498,000 | - |
| 2020 | $0 | - | $-2,346,000 | - | $-15,744,000 | - |
| 2019 | $0 | - | $0 | - | $-10,110,000 | - |
| 2018 | $0 | - | $0 | - | $-111,684,000 | - |
See NAUT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NAUT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NAUT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNAUT — Frequently Asked Questions
Quick answers to the most common questions about buying NAUT stock.
Is NAUT's revenue growth accelerating or slowing?
NAUT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NAUT's long-term revenue growth rate?
Nautilus Biotechnology, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is NAUT's revenue distributed by segment?
NAUT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.